Consistent with the hypothesis that CR-1 sustains a mesenchymal phenotype in PCa cells, downregulation of CR-1 with CR-1-targeted siRNAs led to reduction of some mesenchymal-associated markers including VIM, CDH2, and CD44 (Figure 3G). This evidence concerns the gene CD44 and posterior cortical atrophy.